Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

-Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

Biccler JL, Glimelius I, Eloranta S, Smeland KB, Brown PN, Jakobsen LH et al

J Clin Oncol. 2019 Mar 20;37(9):703-713